M
Marek Minarik
Researcher at Charles University in Prague
Publications - 95
Citations - 1860
Marek Minarik is an academic researcher from Charles University in Prague. The author has contributed to research in topics: Erlotinib & KRAS. The author has an hindex of 25, co-authored 90 publications receiving 1639 citations. Previous affiliations of Marek Minarik include Northeastern University & Massachusetts Institute of Technology.
Papers
More filters
Journal ArticleDOI
Toward Male Individualization with Rapidly Mutating Y‐Chromosomal Short Tandem Repeats
Kaye N. Ballantyne,Kaye N. Ballantyne,Arwin Ralf,Rachid Aboukhalid,Niaz M. Achakzai,Maria João Anjos,Qasim Ayub,Jože Balažic,Jack Ballantyne,David Ballard,Burkhard Berger,Cecilia Bobillo,Mehdi Bouabdellah,Helen Burri,Tomas Capal,Stefano Caratti,Jorge Cárdenas,François Cartault,Elizeu Fagundes de Carvalho,Mónica Carvalho,Baowen Cheng,Michael D. Coble,David Comas,Daniel Corach,Maria Eugenia D’Amato,Sean Davison,Peter de Knijff,Maria Corazon A. De Ungria,Ronny Decorte,Tadeusz Dobosz,Berit Myhre Dupuy,Samir Elmrghni,Mateusz Gliwiński,Sara C Gomes,Laurens J. W. Grol,Cordula Haas,Erin K. Hanson,Jürgen Henke,Lotte Henke,Fabiola Herrera-Rodríguez,Carolyn R. Hill,Gunilla Holmlund,Katsuya Honda,Uta-Dorothee Immel,Shota Inokuchi,Mark A. Jobling,Mahmoud Kaddura,Jong S Kim,Soon H Kim,Wook Kim,Turi E. King,Eva Klausriegler,Daniel Kling,Lejla Kovacevic,Leda Kovatsi,Paweł Krajewski,S. A. Kravchenko,Maarten Larmuseau,Eun Young Lee,R. Lessig,L. A. Livshits,Damir Marjanović,Marek Minarik,Natsuko Mizuno,Helena Moreira,Niels Morling,Meeta Mukherjee,Patrick Munier,Javaregowda Nagaraju,Franz Neuhuber,Shengjie Nie,Premlaphat Nilasitsataporn,Takeki Nishi,Hye H Oh,Jill K. Olofsson,Valerio Onofri,Jukka U. Palo,Horolma Pamjav,Walther Parson,Walther Parson,Michal Petlach,Christopher Phillips,Rafał Płoski,Samayamantri P. R. Prasad,Dragan Primorac,Dragan Primorac,Dragan Primorac,Gludhug A. Purnomo,Josephine Purps,Héctor Rangel-Villalobos,Krzysztof Rębała,Budsaba Rerkamnuaychoke,Danel Rey Gonzalez,Carlo Robino,Lutz Roewer,Alexandra Rosa,Antti Sajantila,Antti Sajantila,Andrea Sala,Jazelyn M. Salvador,Paula Sanz,C. Schmitt,Anil Kumar Sharma,Dayse A. Silva,Kyoung Jin Shin,Titia Sijen,M. Sirker,Daniela Siváková,Vedrana Škaro,Carlos Solano-Matamoros,L. Souto,Vlastimil Stenzl,Herawati Sudoyo,Denise Syndercombe-Court,Adriano Tagliabracci,Duncan Taylor,Andreas O. Tillmar,Iosif S. Tsybovsky,Chris Tyler-Smith,Kristiaan J. van der Gaag,Daniel Vanek,Antónia Völgyi,Denise Ward,Patricia Willemse,Eric P.H. Yap,Rita Y.Y. Yong,Irena Zupanič Pajnič,Manfred Kayser +127 more
TL;DR: The value of RM Y‐STRs in identifying and separating unrelated and related males and providing a reference database is demonstrated and the value of Y‐ STRs relative to Yfiler is demonstrated.
Journal ArticleDOI
Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer
Cyril Salek,L Benesova,Miroslav Zavoral,Vladimír Nosek,L Kasperova,Miroslav Ryska,R Strnad,Eva Traboulsi,Marek Minarik +8 more
TL;DR: EUS-guided FNA cytology combined with screening of K-ras mutations and allelic losses of tumor suppressors p16 and DPC4 represents a very sensitive approach in screening for pancreatic malignancy.
Journal ArticleDOI
Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients
L Benesova,Barbora Belsanova,Stepan Suchanek,Marta Kopeckova,Petra Minarikova,Ludmila Lipska,Miroslav Levy,V. Visokai,Miroslav Zavoral,Marek Minarik +9 more
TL;DR: Apart from conventional mutation detection approaches, several dedicated techniques have been presented to detect low levels of cfDNA in an excess of nontumorous (nonmutated) DNA, including real-time polymerase chain reaction (PCR), "BEAMing" (beads, emulsion, amplification, and magnetics), and denaturing capillary electrophoresis.
Journal ArticleDOI
Molecular biology of pancreatic cancer.
TL;DR: Understanding of the underlying molecular mechanisms should promote development of new methodology for early diagnosis and facilitate improvement in current approaches for pancreatic cancer treatment.
Journal ArticleDOI
Colorectal cancer screening: 20 years of development and recent progress
Miroslav Zavoral,Stepan Suchanek,Ondrej Majek,Premysl Fric,Petra Minarikova,Marek Minarik,Bohumil Seifert,Ladislav Dušek +7 more
TL;DR: The Czech Republic is a typical example of a country with a long history of nationwide CRC screening programs in the face of very high CRC incidence and mortality rates, and switching to the option of a population-based program with personal invitation is currently being prepared.